Top Markets
#1 PulseChain PulseChain +45.01%
#2 SkyAI SkyAI +11.41%
#3 Meteora Meteora +10.48%
#4 Unit Pump Unit Pump +10.28%
#5 Pump.fun Pump.fun +10.28%
#6 eCash eCash +8.55%
#7 OPENLOOT OPENLOOT +8.41%
#8 Glidr Glidr +6.76%
#9 Ergo Ergo +6.51%
#10 Qkacoin Qkacoin +6.46%
Coin of the day
PulseChain PulseChain
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Lukas Biomedical Inc. Lukas Biomedical Inc.

Lukas Biomedical Inc.

6814
Rang in aandelen #27947
Founded in 2002 and headquartered in New Taipei, Taiwan, Lukas Biomedical Inc.... Founded in 2002 and headquartered in New Taipei, Taiwan, Lukas Biomedical Inc. primarily develops immune cell medical technologies. These innovations are utilized for regenerative medicine and as complementary treatments for cancer. The company's operations are segmented into four distinct areas: E-commerce, Medical Management Business, Cell Product, and Pharmaceutical Market. Furthermore, it diversifies its business by wholesaling and retailing cosmetics, alongside providing housing equipment rental services.
Aandeelprijs
$0.70593842
Laatst gesynchroniseerd: 2026-08-19
Marktkapitalisatie
$29.56M
Verandering (1 dag)
-0.45%
Verandering (1 jaar)
-9.76%
Land
TW
Handel Lukas Biomedical Inc. (6814)

Categorie

Healthcare
Dividendrendementgeschiedenis voor Lukas Biomedical Inc. (6814)
Het dividendrendement (TTM) van Lukas Biomedical Inc. (aandelsymbool: 6814) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Lukas Biomedical Inc. (6814) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten
Bedrijf Dividendrendement Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH